AFFIMED N.V.       EO-,10
AFFIMED N.V. EO-,10
Share · NL0015001ZQ0 · AFMD · A407ZR (XNCM)
Overview Financial Indicators
0,15 EUR
-13,88 % -0,02 EUR
Frankfurt (XNAS) · Current prices and charts at MoneyPeak
19.05.2025 23:59

Current Prices from AFFIMED N.V. EO-,10

ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
AFMD
USD
19.05.2025 23:59
0,17 USD
0,29 USD
-40,96 %

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
1,95 % 2,13 % -74,89 % -82,84 % -93,43 % -97,30 % -99,47 %

Company Profile for AFFIMED N.V. EO-,10 Share

Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in Phase I clinical trial for hodgkin lymphoma. The company is also developing AFM24, a tetravalent, bispecific epidermal growth factor receptor, and CD16A-binding innate cell engager, which is in Phase IIa clinical trial for the treatment of advanced cancers; AFM28, an innate cell engager (ICE), which is in preclinical development to treat acute myeloid leukemia; and AFM32, an ICE candidate that is in preclinical development for the treatment of solid tumors. Affimed N.V. has collaboration agreements with The University of Texas MD Anderson Cancer Center; Genentech, Inc.; and Roivant Sciences Ltd., as well as research funding agreement with The Leukemia & Lymphoma Society. The company was formerly known as Affimed Therapeutics B.V. and changed its name to Affimed N.V. in October 2014. Affimed N.V. was founded in 2000 and is headquartered in Heidelberg, Germany.

Company Data

Name AFFIMED N.V. EO-,10
Company Affimed N.V.
Symbol AFMD
Website https://www.affimed.com
Primary Exchange XNCM Frankfurt
WKN A407ZR
ISIN NL0015001ZQ0
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Dr. Shawn M. Leland Pharm.D., R.Ph.
Market Capitalization 11 Mio
Country Germany
Currency EUR
Employees 0,1 T
Address Technologiepark, 69120 Heidelberg
IPO Date 2014-09-12

Ticker Symbols

Name Symbol
Frankfurt A28A.F
NASDAQ AFMD

More Shares

Investors who AFFIMED N.V. EO-,10 hold also have the following shares in their portfolio:
LAUSANNE 20/56
LAUSANNE 20/56 Bond
NORTECH SYSTEMS INC
NORTECH SYSTEMS INC Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025